UK company announcements filtered and explained for private investors.
Computacenter PLC (CCC) · 2026-10-26
Computacenter PLC said Q3 trading was ahead of its expectations and raised FY 2026 adjusted profit before tax guidance to no less than £425m, despite a decline in Managed Services revenue being more than offset by Professional Services growth.
Castings PLC (CGS) · 2026-10-26
Castings PLC has cut its FY27 adjusted profit-before-tax expectation to broadly the prior-year level excluding historical R&D tax credits, versus pre-update analyst consensus of £12.9m, as unresolved production arrears and catch-up costs persist after a power-supply issue. FY27 revenue expectations remain in line with £181.1m consensus.
Plus500 Ltd (PLUS) · 2026-10-26
Plus500 Ltd expects FY 2026 revenue and EBITDA to be ahead of current market expectations after Q3 revenue rose 11% to $203.2m and EBITDA rose 7% to $88.4m. Nine-month interest income fell to $32.1m from $50.7m as global rates fell, although stronger trading income lifted nine-month revenue 11% to $666.1m.
Greatland Resources Ltd (GGP) · 2026-10-26
Greatland’s September quarter was better than plan for gold production and AISC, according to management, but gold and copper output and net revenue fell from the June quarter while AISC rose. It remains on track for FY27 guidance and ended the quarter debt free with A$1.789 billion of available liquidity.
Bioventix PLC (BVXP) · 2026-10-26
Bioventix PLC said FY2026 revenue and profit after tax were slightly ahead of market expectations, but reported revenue fell to £13.0m from £13.1m as legacy products faced pressure. A terminated progesterone-antibody contract will remove about £400,000 of annual revenue from future periods.
Sareum Holdings PLC (SAR) · 2026-10-26
Sareum Holdings has conditionally raised about £3.2m before expenses at 14p per share, a roughly 49% discount to the pre-pause price, to fund SDC-1801 towards Phase 2 readiness, neuroscience work and working capital. The funding remains conditional on AIM admission.
Safestay PLC (SSTY) · 2026-10-26
Safestay PLC said year-to-date trading remains below the Board’s original expectations, although recent trading has shown signs of improvement. Liquidity pressure persists into the quieter winter months. Bank borrowings fell to £9.1 million at 23 October 2026 from £13.6 million at 30 June 2026 after property-sale proceeds were used to reduce debt.
Airtel Mobile Commerce N.V. (AMC) · 2026-10-26
Airtel Mobile Commerce N.V. said H1 FY’27 was in line with management expectations: revenue reached USD 830m, up 25.1% in constant currency, but underlying EBITDA margin fell to 48.0% from 50.8% after intra-group agreement changes and a DRC levy. Underlying EBITDA rose to USD 398m and operating free cash flow increased to USD 378m from USD 297m.
Cizzle Biotechnology Holdings PLC (CIZ) · 2026-10-26
Cizzle Biotechnology Holdings has conditionally raised £500,000 before expenses from existing shareholder Frazer Lang and is converting £250,000 of loan notes into shares, but the second subscription tranche remains subject to conditions. The financing also grants 62,500,000 warrants at 1.2p, expiring on 1 October 2031, and reprices 22,500,000 existing warrants to 1.2p with the same expiry; 25,000,000 new warrants depend on second-tranche admission.
Orosur Mining Inc (OMI) · 2026-10-26
Orosur Mining’s explicit going-concern uncertainty persists, although its October private placement raised C$16.0 million gross and the Company said cash, including those funds, was US$16.840 million at the MD&A date.
Critical Metals PLC (CRTM) · 2026-10-26
Critical Metals PLC remained pre-revenue in the year to 30 June 2026. Its operating loss before exceptional items narrowed to £980,902 from £1,841,511, but the reported pre-tax loss was also helped by an £842,991 debt-forgiveness gain; material going-concern uncertainty remains because operations depend on external funding.
Quadrise PLC (QED) · 2026-10-26
Quadrise PLC has launched a Strategic Review, but widening losses, falling cash and the need for further uncommitted funding before positive cash flow leave a material going-concern uncertainty. The review covers partnership, licensing, joint-venture, investment and acquisition options, but Quadrise is not seeking offers for the Company.
One Health Group PLC (OHGR) · 2026-10-26
One Health Group PLC grew H1 27 revenue 17% to £18.3 million, but the Board remains on track to deliver FY27 revenue growth and underlying EBITDA in line with current market expectations amid possible NHS commissioning disruption in the second half. Underlying EBITDA for H1 27 is expected to exceed the £1.18 million reported for H1 FY26 as activity increased.
Hutchmed (China) Ltd (HCM) · 2026-10-26
Hutchmed reported Phase III data showing ORPATHYS plus TAGRISSO improved median progression-free survival to 7.6 months from 5.4 months and median overall survival to 17.8 months from 12.9 months versus chemotherapy. A US NDA has been submitted, but any broader commercial benefit remains subject to regulatory progress.
Eagle Eye PLC (EYE) · 2026-10-26
Eagle Eye PLC has launched an up-to-£1.0m share buyback from today, funded from existing cash, but purchases are not certain and remain subject to sufficient distributable reserves and market conditions.
GSK PLC reported strong phase I Mo-Rez activity in platinum-resistant ovarian cancer, but 71% of patients had grade 3-or-higher treatment-related adverse events. At the selected phase III dose, confirmed objective response was 62% (28/45), with median response duration of 12.2 months and median progression-free survival of 11.1 months after more than 13 months’ follow-up.
Molten Ventures plc (GROW) · 2026-10-26
Molten expects unaudited NAV per share at 30 September 2026 to rise 14% to circa 869p, despite £90 million of fair-value reductions and a £10 million adverse foreign-exchange movement, versus 724p a year earlier and 760p at 31 March 2026. Unaudited GPV is expected to rise 11% to circa £1.695 billion from £1.525 billion at 31 March 2026; total fair-value movements were £234 million, or 15.3% of opening GPV.
Angus Energy PLC (ANGS) · 2026-10-26
Angus Energy’s estimated Q3 2026 revenue fell 8% quarter-on-quarter to £6.60 million from £7.16 million as planned maintenance reduced production, although the work was completed and borrowings fell.
Brave Bison Group PLC (BBSN) · 2026-10-26
As at 3.00 p.m. on 23 October 2026, Brave Bison Group PLC could count 40.16% of System1’s existing issued share capital towards its offer’s Acceptance Condition, including valid acceptances for 12.31%, but this does not establish completion or control. It says the Final Offer’s financial terms are final, subject to specified exceptions.
Cobra Resources PLC (COBR) · 2026-10-26
Cobra Resources has defined a maiden JORC-compliant 150 Mt Wudinna rare-earth resource grading 470 ppm TREO, but it is not an Ore Reserve and economic viability has not been demonstrated. The estimate provides the resource base for a planned Scoping Study.
GSK PLC reported positive interim AZUR-1 results for Jemperli in locally advanced MSI-H/dMMR rectal cancer, but the independently reviewed primary endpoint is still maturing. The trial met its primary objective, while regulatory reviews continue outside the US.
Helix Exploration PLC (HEX) · 2026-10-26
Helix Exploration has spudded Ross #1, intended as the fifth production well in Rudyard’s Northern Dome, but any tie-in to the PSA Plant remains subject to flow testing and gas analysis. The company has also resumed continuous tube-trailer filling after restarting production.
Nativo Resources PLC (NTVO) · 2026-10-26
Nativo Resources has awarded StratumX detailed design and construction engineering work for its La Patona gold plant, moving the project from FEED into the engineering, procurement and construction stage. Phase 1 funding is stated to be secured through a non-dilutive gross revenue share arrangement with Chancery Royalty, announced on 18 September 2026.
Neoterra Group PLC (TERA) · 2026-10-26
Neoterra Group has met the Phase 3 spending requirement under its Farm-Out Agreement, triggering an increase in its interest in Monte Muambe Mining Limitada from 51% to 70%, but the share-transfer formalities are still incomplete.
Bluebird Mining Ventures Ltd (BMV) · 2026-10-26
Bluebird Mining Ventures Ltd has started a share buyback programme, but the £300,000 and 350 million-share limits are maximums rather than committed purchases. Shares bought will initially be held in treasury, not cancelled.
Kistos Holdings PLC (KIST) · 2026-10-26
Kistos Holdings has placed a USD 50 million tap of its 9.875% senior secured bonds, subject to customary closing conditions, taking total bonds outstanding to USD 350 million. On settlement, it expects USD 250 million to USD 300 million of liquidity, complemented by cash flows from its unhedged production portfolio.
TEK4 Group PLC (TEK4) · 2026-10-26
TEK4 Group PLC has joined AIM and raised £2.0 million for the Company through a 200p placing, while £22.75 million of the £24.75 million aggregate proceeds went to selling shareholders. Dealings began at 8:00am under ticker TEK4.
Blencowe Resources PLC (BRES) · 2026-10-26
Blencowe Resources PLC reported graphite surface outcrops along an approximately 25km trend outside its existing mine plan, which it assesses as initially supportive of potential for 2–3 billion tonnes of mineralisation; however, the work is preliminary and the grab samples were selective rather than representative.
Georgina Energy PLC (GEX) · 2026-10-26
Georgina Energy PLC’s mobilisation of Ensign Rig 970 to Hussar EP513 is delayed by heavy-vehicle road closures and variable weather, so drilling has not started and no revised spud date has been given. Civil and site works are complete, while WMOG pursues road-access discussions and an alternative route.
IG Group Holdings PLC (IGG) · 2026-10-26
IG Group Holdings PLC’s CFO, Clifford Abrahams, bought 10,000 shares for £94,399.10 on 23 October 2026.
Aptamer Group PLC (APTA) · 2026-10-26
Aptamer Group has begun a cost-sharing preclinical collaboration with Pharmahungary to develop Optimer delivery vehicles for heart and skeletal muscle. Aptamer says the work needs no unbudgeted spend and does not alter its cash-runway projections, but any pharmaceutical licensing remains conditional on successful preclinical results.
Pensana Rare Earths PLC (PRE) · 2026-10-26
Pensana Rare Earths is discussing US$75-90 million of equity funding for Ozango, but Longonjo construction is slowed until the financing is concluded. Cascade expects to deploy a significant tranche within 14 days, although the funding remains under discussion.
First Class Metals PLC (FCM) · 2026-10-26
First Class Metals reported further high-grade grab samples across more than 100 metres at its Roy northeast visible-gold zone, supporting a gold anomaly of about 300 metres that remains open along strike. The samples may be selective and may not represent average mineralisation.
Avacta Group PLC (AVCT) · 2026-10-26
Avacta reported median progression-free survival of 11.4 months in a selected 32-patient salivary gland cancer subset treated with faridoxorubicin at 310 mg/m2 or above, which it said was nearly double published historical benchmarks of 6-6.7 months. The early Phase 1a/1b dataset, historical comparison and subset exclusions limit what the data can show about comparative efficacy.
Puretech Health PLC (PRTC) · 2026-10-26
Puretech Health PLC reported encouraging Phase 1b LYT-200 data in a small, heavily pretreated high-risk MDS cohort, but progression to Phase 2 depends on external funding for its wholly owned Gallop Oncology unit.
1947 Oil & Gas plc (1947) · 2026-10-26
1947 Oil & Gas plc restored Eugene Island 331 production after an extended repair shut-in and lifted Ship Shoal 198 output following a workover. Net production is about 1,000 boepd at Eugene Island and 1,060 boepd at Ship Shoal, versus a 545 boepd net average at Ship Shoal in the first half of 2026; management said the developments were in line with the Company’s expectations.
Great Southern Copper PLC (GSCU) · 2026-10-26
Great Southern Copper PLC has secured permits and is mobilising a rig for up to 5,000m of Phase IV drilling at Cerro Negro. The programme could extend and infill Mostaza and provides the first drill test of the nearby Monolith prospect, but results are still pending.
Marechale Capital PLC (MAC) · 2026-10-26
Marechale Capital has completed three strategic acquisitions during the year and fully integrated Blubird’s platform as it builds what it describes as a digital merchant bank. The Group is still bringing its expanded businesses together, while management reports early cross-sell opportunities.
Sareum Holdings PLC (SAR) · 2026-10-26
Sareum Holdings PLC has launched a conditional UK retail offer of up to £100,000 at 14p per share, alongside an earlier approximately £3.2 million subscription at the same price. The retail offer depends on completion of the subscription and admission of its shares to AIM.
Man Group PLC (EMG) · 2026-10-26
Man Group PLC has expanded its partnership with Meiji Yasuda, which intends to raise its capital commitment to Man Group investment strategies to JPY200 billion (about $1.25 billion) over the next three years, particularly in private credit. The commitment is an intention, not a disclosed binding contract.
Restore PLC (RST) · 2026-10-26
Restore PLC has set out an orderly senior management transition: Dan Baker is due to become Chief Executive Officer on 1 January 2027, with Ian Melling succeeding him as Chief Financial Officer and joining the board on 11 January 2027.
Rome Resources PLC (RMR) · 2026-10-26
Rome Resources has identified a 2.6km tin-bearing zone at Scoullar Mountain, but assays are pending. It has also elected to acquire 100% of the working interest in its New Brunswick claims.
Focus Xplore PLC (FOX) · 2026-10-26
Focus Xplore PLC has begun Phase 1 prospecting and soil geochemical sampling at its Garden Lake Properties in northwestern Ontario, backed by £37,000 from its recent £0.5 million fundraise. The targets are untested for gold, and nearby Conick Lake gold samples are outside the properties and are not necessarily indicative of mineralisation there.
Unicorn Mineral Resources PLC (UMR) · 2026-10-26
Unicorn Mineral Resources has reshaped its board with Patrick Doherty becoming Executive Chairman, two new non-executive directors joining, and Antony Legge and Jason Brewer leaving as directors. The company says the changes support the next development phase at the Klein Aub Copper Mine in Namibia, but they provide no operating or financial outcome.
GoldStone Resources Ltd (GRL) · 2026-10-26
GoldStone Resources’ Homase drilling supports potential pit expansion and resource work, but a low-grade central zone still needs assessment and the results are preliminary. The company has completed northern pit-definition work and five southern holes, and has appointed SEMS for the next exploration phase.
BSF Enterprise PLC (BSFA) · 2026-10-26
BSF Enterprise said its Lab-Grown Leather subsidiary has moved into partner-funded evaluation programmes with two global luxury fashion houses, with samples delivered and milestone invoices submitted under one programme. The work remains pre-commercial: further testing must meet luxury-usability thresholds before any PoC or supply agreement.
Auction Technology Group PLC (ATG) · 2026-10-26
Auction Technology Group faces a shareholder-led board challenge after FitzWalter Capital, its 27.2% largest shareholder, requisitioned a General Meeting to replace director Scott Forbes with Richard Campbell-Breeden. A strategic review, buyback or potential sale would remain conditional on shareholder votes, a new Chair and board approval.
Auction Technology Group PLC (ATG) · 2026-10-26
Auction Technology Group faces a proposed board change that could lead to a strategic review and consideration of a competitive sale process, but FitzWalter Capital does not intend to bid for the company.
CLS Holdings PLC (CLI) · 2026-10-26
CLS Holdings expects to leave the UK REIT regime on 31 December 2026 after ownership changes outside its control made it a close company. From 1 January 2027, rental profits and property-sale profits are expected to lose their corporation-tax exemption, although CLS says its property strategy will be unaffected.
Software Circle PLC (SFT) · 2026-10-26
Software Circle has acquired Gintech, owner of private-healthcare software provider Midexpro, for up to £4.5m on a debt-free/cash-free basis. It paid £2.6m at completion, with £0.6m deferred and up to £1.3m contingent on Midexpro meeting annual recurring revenue and EBITDA targets over two years.
Unilever PLC (ULVR) · 2026-10-26
Unilever PLC said Ruby Lu resigned from its Board with effect from 24 October 2026.
Panthera Resources PLC (PAT) · 2026-10-26
Panthera Resources has completed the written phase of Phase One in its US$1.58 billion treaty claim against India, but says the outcome remains uncertain and any damages calculation depends on succeeding in this phase.
Big Technologies PLC (BIG) · 2026-10-26
Big Technologies PLC has been served with Particulars of Claim in Sara Murray’s defamation action. The Company robustly disputes the claim and is preparing its response.
EnergyPathways PLC (EPP) · 2026-10-26
EnergyPathways PLC has signed Heads of Terms to buy land for MESH, a conditional step that it says could enable vital pipeline links and advance the project towards a Final Investment Decision.
Empyrean Energy PLC (EME) · 2026-10-26
Empyrean Energy expects to acquire a 10% economic interest in the GOLD Cluster in Upper Austria, subject to an Exploration and Investment Agreement and related partnership agreements being finalised. Site construction is scheduled to start on 27 October 2026, with GOLD-1 drilling expected in the first week of January 2027.
Nationwide Building Society (NBS) · 2026-10-26
Nationwide Building Society has given notice to redeem its £650m 6.178% senior non-preferred notes in full on 7 December 2026, having satisfied the applicable redemption preconditions or requirements. The notes will then be cancelled.